Apr. 29 - Speaking at the Milken Institute Global Conference, hedge fund manager Jeffrey Ubben of ValueAct says Microsoft could see a lot of upside and thinks its enterprise software holds the key. Ubben also says a Valeant-Allergan tie-up is a perfect match.
▲ Hide Transcript
▶ View Transcript
Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code